Embecta Corp. (EMBC)
- Previous Close
14.20 - Open
14.28 - Bid 14.43 x 100
- Ask 14.48 x 100
- Day's Range
13.96 - 14.63 - 52 Week Range
9.93 - 28.99 - Volume
369,436 - Avg. Volume
431,520 - Market Cap (intraday)
833.334M - Beta (5Y Monthly) 0.82
- PE Ratio (TTM)
11.84 - EPS (TTM)
1.22 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield 0.60 (4.15%)
- Ex-Dividend Date May 28, 2024
- 1y Target Est
15.00
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
www.embecta.com2,200
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: EMBC
Performance Overview: EMBC
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMBC
Valuation Measures
Market Cap
833.33M
Enterprise Value
2.17B
Trailing P/E
11.84
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.74
Price/Book (mrq)
--
Enterprise Value/Revenue
1.92
Enterprise Value/EBITDA
11.06
Financial Highlights
Profitability and Income Statement
Profit Margin
6.20%
Return on Assets (ttm)
9.74%
Return on Equity (ttm)
--
Revenue (ttm)
1.13B
Net Income Avi to Common (ttm)
70.2M
Diluted EPS (ttm)
1.22
Balance Sheet and Cash Flow
Total Cash (mrq)
299.8M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
44.26M
Research Analysis: EMBC
Company Insights: EMBC
EMBC does not have Company Insights